Tuberculosis Research and Epidemiology -- 专题文献

近5年高被引文献

CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database

article Full Text OpenAlex 1858 FWCI121.9992

WHO's Global Tuberculosis Report 2022

article Full Text OpenAlex 1107 FWCI109.1654

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

article Full Text OpenAlex 555 FWCI96.9346

Immune evasion and provocation by Mycobacterium tuberculosis

review Full Text OpenAlex 536 FWCI50.5791

Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

article Full Text OpenAlex 519 FWCI49.0618

Anti-tuberculosis treatment strategies and drug development: challenges and priorities

review Full Text OpenAlex 449 FWCI42.3853

The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB

review Full Text OpenAlex 403 FWCI40.1598

Transboundary and Emerging Diseases

paratext Full Text OpenAlex 398 FWCI0

Perceptions of healthcare professionals and patients on the role of the pharmacist in TB management in Pakistan: A qualitative study

article Full Text OpenAlex 369 FWCI36.9092

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

article Full Text OpenAlex 325 FWCI30.7521

专题：Tuberculosis Research and Epidemiology

最新文献

**Membrane microdomains are crucial for Mycobacterium marinum EsxA-dependent membrane damage, escape to the cytosol, and infection**

Individuals with latent tuberculosis in a high TB endemic country show mild COVID-19

Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis

Efficacy of isoniazid in paediatric tuberculosis: an individual participant data meta-analysis

**Intracellular Acinetobacter baumannii acts as a transient reservoir in lung infection via a “persist and resist” strategy**

[Fe(phen) ₃ ] ²⁺ and [Fe(phen) ₃ ] ²⁺ -Loaded Nanostructured Lipid System: In Silico, In Vitro, and In Vivo Efficacy against Mycobacterium tuberculosis

From dependence to self-reliance: The future of the global tuberculosis response

Comparative safety profile of levofloxacin versus moxifloxacin in first-line tuberculosis therapy: a pharmacovigilance study of the FAERS database

Mycobacterium tuberculosis overcomes phosphate starvation by extensively remodelling its lipidome with phosphorus-free lipids

Advanced Nanosystems and Emerging Therapies: Innovations in Tuberculosis Treatment and Drug Resistance

近5年高被引文献

CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database

WHO's Global Tuberculosis Report 2022

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

Immune evasion and provocation by Mycobacterium tuberculosis

Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

Anti-tuberculosis treatment strategies and drug development: challenges and priorities

The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB

Transboundary and Emerging Diseases

Perceptions of healthcare professionals and patients on the role of the pharmacist in TB management in Pakistan: A qualitative study

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

专题：Tuberculosis Research and Epidemiology

最新文献

Membrane microdomains are crucial for Mycobacterium marinum EsxA-dependent membrane damage, escape to the cytosol, and infection

Individuals with latent tuberculosis in a high TB endemic country show mild COVID-19

Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis

Efficacy of isoniazid in paediatric tuberculosis: an individual participant data meta-analysis

Intracellular Acinetobacter baumannii acts as a transient reservoir in lung infection via a “persist and resist” strategy

[Fe(phen) 3 ] 2+ and [Fe(phen) 3 ] 2+ -Loaded Nanostructured Lipid System: In Silico, In Vitro, and In Vivo Efficacy against Mycobacterium tuberculosis

From dependence to self-reliance: The future of the global tuberculosis response

Comparative safety profile of levofloxacin versus moxifloxacin in first-line tuberculosis therapy: a pharmacovigilance study of the FAERS database

Mycobacterium tuberculosis overcomes phosphate starvation by extensively remodelling its lipidome with phosphorus-free lipids

Advanced Nanosystems and Emerging Therapies: Innovations in Tuberculosis Treatment and Drug Resistance

近5年高被引文献

CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database

WHO's Global Tuberculosis Report 2022

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

Immune evasion and provocation by Mycobacterium tuberculosis

Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

Anti-tuberculosis treatment strategies and drug development: challenges and priorities

The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB

Transboundary and Emerging Diseases

Perceptions of healthcare professionals and patients on the role of the pharmacist in TB management in Pakistan: A qualitative study

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

**Membrane microdomains are crucial for Mycobacterium marinum EsxA-dependent membrane damage, escape to the cytosol, and infection**

**Intracellular Acinetobacter baumannii acts as a transient reservoir in lung infection via a “persist and resist” strategy**

[Fe(phen) ₃ ] ²⁺ and [Fe(phen) ₃ ] ²⁺ -Loaded Nanostructured Lipid System: In Silico, In Vitro, and In Vivo Efficacy against Mycobacterium tuberculosis